The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Aimhigherstill
my reputation is I call on the very bottom of Share price and let people know,
because when good news comes it's hard to buy in good quantities without Going NT.
and they fact Most on AIM like to pay higher price is crazy.
example
I bought #bloe 0.93
now peeps buying at 2p
that's 100% higher than what I paid.
why don't you guys get it......
buy when no one wants them...... sell when all wants in.....
I'm not here for popular votes pal.
see opportunities and take action
GLA
Some saying 50p on the Rns on ADVFN..... won't disagree with them
looking at the $11 billion Market Size and growing fast this could become AIM most valuable companies in the future.
GLA and Dyor before its too late.
The Heart Valves Market in 2023 is US$ 11.55 billion, and is expected to reach US$28.45 billion by 2031 at a CAGR of 11.92%. The heart valves market is a dynamic and rapidly growing industry that plays a crucial role in the field of cardiovascular healthcare.4 Jan 2024
Late print buy just popped up 100k
mms tried hiding this
look how AGL risen on £150k contract announcement to
now RUA Announcement would be in $10m+ minimum because heart valve market is worth multiple of billion dollars
Bill Brown, Chairman of RUA said: "The mutual benefits of this partnership with Corcym are transformational for RUA. Not only does it validate our belief in the product range but it is backed up with Corcym's capacity and capabilities to make the graft range available to heart surgeons globally."
Christian Mazzi , CEO of Corcym added : "Corcym is excited to partner with an innovative company like RUA to commercialise the aortic graft range. Corcym's mission is to help cardiac surgeons treat patients better, today and in the future, and RUA's aortic graft range will be an important addition to the product portfolio we can offer Heart Surgeons worldwide
Talks for heart valve, unique design and patented
Read Rns
Ast not used any Riverfort Service in the last Few years
So that's a good indication,
Plus
#Ast will be with the big boys in the #Usa #helium processing, Purification, Liquification and transportation
Big cake with big slice for #Ast
Let this sink in
However, as a consequence of the above delay, the cash position of the Group has further declined during December 2023. The Company has been unable to meet December 2023 payroll in full and therefore the Company's Directors and senior management have agreed to defer their salaries and fees until such time as the delayed funds are received. The Company has asked certain employees to defer on the same basis, and is pleased that in excess of 67% of Group staff have agreed to full deferral, with a significant additional number agreeing to partial deferral.
Ahanda
stop comparing a loss making, cash burning company to a UK corner shop which is in a different league.
SND could do with a placing to give them breathing space for longer life,
but get this..... directors wants to crash sp
The asset must be worth billions for GNG to $16.5m to aquire it......
the former company probably ran out of cash to continue, who knows but many times bargain hunters picks up huge assets for small fees.
this is no way small.
massive potential for helium processing, Purification and liquification, then to transport it.
money to be made in every chain of the line here
AST has done well to get in before any other companies did
GNG to Partners LLC bought Paradox Estate for total $16m.5
why would GNG be willing to pay $16.5m had they not seen the value of this transaction?
all the time companies buy bankrupt companies that's not a bad move, that's a clever move
The Chapter 11 documentation sets out that the Lisbon Plant is the sole operating natural gas processing plant in the Paradox Basin and is fed by over 500 miles (of which 279 miles are wholly-owned by GNG) of helium rich gas gathering pipelines which have access to helium rich gas sources with 7-8% He concentration in the four corners region, most notably in SE Utah and NW New Mexico. The Lisbon Plant is a 60 MMcfd (million cubic feet per day) gas treatment plant which has a 1.1 MMcfd processing capacity for helium, a 45 MMcfd cryogenic plant and 10 MBpd (thousand barrels per day) fractionation train. The plant was built specifically to process the Paradox Basin natural gas that often has high CO2, H2S, N2 and He content. GNG believe that the Lisbon Plant can produce approximately 3.4% of the US liquid helium production (or 1.7% of the World's liquid helium). The Lisbon Plant is currently operational and processing gas and purifying helium which is sold as gaseous helium directly to industrial consumers via truck. The Lisbon Plant has a liquification unit which has been in care and maintenance since around 2013 (when the liquified helium price was only ~US$62.25 /Mcf versus the US$750-1,250 /Mcf range available today).